Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Community Practice Connections™: Navigating a New Era of Food Allergy Management
View More
Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Arizona
View More
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Nevada
View More
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Missouri
View More
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | New Mexico
View More
Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 66th ASH Annual Meeting
April 26-27, 2025
Register Now!
Handwashing: An Infection Prevention Method That We Forget?
May 15th 2025Robert Hopkins Jr, MD, the medical director of the National Foundation for Infectious Diseases discusses the results of the organization's new survey and the surprising findings that many people forget to wash their hands after key times or believe it is not needed.
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
May 14th 2025A small percentage of people who contract the tick-borne illness have lingering symptoms and health issues after the acute infection has been treated, but there are no FDA-approved therapies to deal with prolonged symptoms. A new report looks to address this issue.
Pertussis: Another Vaccine-Preventable Disease Seeing a Major Resurgence
May 14th 2025Pertussis, also known as whooping cough, saw more cases last year than in the last decade, and it is on track for another record year for cases. Sharon Nachman, MD, provides clinical insights for presentation, treatment, and vaccination.
Global Study Reports 98.9% SVR with SOF/VEL in Over 7000 Patients With Hepatitis C
May 14th 2025Multinational real-world analysis underscores the effectiveness of sofosbuvir/velpatasvir (SOF/VEL) across diverse populations and highlights the need for timely treatment initiation to improve patient outcomes.
FDA and CDC Recommend Pause on Chikungunya Vaccine IXCHIQ for Adults 65 and Older
Regulatory action follows reports of serious adverse events during use in elderly individuals; vaccine remains authorized for younger age groups in the US and Europe with over 40,000 doses administered globally.
Hepatitis D Patients Maintain Undetectable Virus Nearly 2 Years After Bulevirtide Therapy
May 10th 2025Anu Osinusi, MD provides insights on the findings of Gilead’s investigational therapy from its phase 3 MYR301 study, which are being reported at the ongoing European Association for the Study of the Liver (EASL) Congress 2025.
US Businesses Are Here to Help the Trump Administration Keep its Pledge to End HIV
May 9th 2025A coalition of over 100 US companies is supporting the federal initiative to end the HIV epidemic by 2030, but legal and funding threats now jeopardize this progress and the significant health and economic benefits it promises.